<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03574090</url>
  </required_header>
  <id_info>
    <org_study_id>1234</org_study_id>
    <nct_id>NCT03574090</nct_id>
  </id_info>
  <brief_title>Study the Efficacy of Topical Antibiotherapy in the Prophylaxis of Incisional Surgical Infection in Urgent Surgery</brief_title>
  <acronym>PROFITOP</acronym>
  <official_title>PROFITOP: Study of the Efficacy of Topical Antibiotherapy in the Prophylaxis of Incisional Surgical Localization Infection in Urgent Dirty/Contaminated Surgery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Universitat Internacional de Catalunya</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Hospital de Granollers</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Universitat Internacional de Catalunya</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The main objective is to study the efficacy of topical antibiotic therapy with Amoxicillin /
      Clavulanic acid in the prevention of surgical wound infection in patients undergoing
      emergency surgery for intra-abdominal infection
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Is a clinical trial phase IV prospective, blind, controlled and random allocation of
      treatment with the active principle of amoxicillin 1000mg and 200mg Clavulanic acid,
      administered topically and dissolved in 500 ml of saline 0.9%. To demonstrate its
      effectiveness in the surgical wound infection prophylaxis be used in dirty/contaminated
      emergency surgery and be compared its effectiveness with the topical administration of normal
      saline only.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">October 20, 2018</start_date>
  <completion_date type="Anticipated">August 15, 2020</completion_date>
  <primary_completion_date type="Anticipated">June 15, 2020</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Triple (Participant, Care Provider, Investigator)</masking>
    <masking_description>In the operating room area we will keep a notebook with the random number sheet and a box with the numbered envelopes and containing the treatment to follow: physiological saline alone or physiological saline with antibiotic. At the end of the surgery and before closing the abdominal wall, it is definitively informed to the nurse whether or not to recruit them, a case number is assigned chronologically and in the random number sheet corresponds to an envelope containing one of the two treatments. Dilution is performed with 10cc of physiological saline solution with or without antibiotic in the outside of the operating room and then it is incorporated into the 500cc bottle of physiological saline once opened in a sterile way. We used according to the usual protocol.</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Evaluation of the effect of topical antibiotic prophylaxis on the incidence of SSI</measure>
    <time_frame>30 days</time_frame>
    <description>Evaluation of the effect of topical antibiòtic ( Amoxicillin 1000mg and 200mg of Clavulanic acid dissolved in 500 milliliters of 0.9% Physiological Serum ) prophylaxis on the incidence of Surgical Site Infection in surgery due to emergency intra-abdominal infection</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>reduction of hospital stay</measure>
    <time_frame>30 days</time_frame>
    <description>Effect of the protocol of topical prophylaxis in the reduction of hospital stay</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Bacterial charge</measure>
    <time_frame>30 days</time_frame>
    <description>Effect of topical prophylaxis protocol on reducing bacterial charge</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Bacterial resistance</measure>
    <time_frame>30 days</time_frame>
    <description>Effect of topical prophylaxis protocol on Bacterial resistance</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">140</enrollment>
  <condition>Surgical Wound Infection</condition>
  <condition>Postoperative Wound Infection</condition>
  <condition>Postoperative Wound Infection Superficial Incisional</condition>
  <condition>Preventive Therapy</condition>
  <arm_group>
    <arm_group_label>amoxicillin clavulanate</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>1000 mg amoxicillin and potassium clavulanate equivalent to 200mg of clavulanic acid. administered topically and dissolved in 500 ml 0.9% Physiological Serum.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Physiological Saline</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>500 milliliters of 0.9% Physiological Serum.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Amoxicillin Clavulanate</intervention_name>
    <description>To demonstrate its efficacy in the prophylaxis of infection to surgical wound will be used in dirty/contaminated emergency surgery and its efficacy will be compared with topical administration of physiological serum alone.</description>
    <arm_group_label>amoxicillin clavulanate</arm_group_label>
    <other_name>1000 mg amoxicillin and 200mg clavulanic acid.</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Physiological Saline</intervention_name>
    <description>To demonstrate its efficacy in the prophylaxis of infection to surgical wound will be used in dirty/contaminated emergency surgery and its efficacy will be compared with topical administration of physiological serum alone.</description>
    <arm_group_label>Physiological Saline</arm_group_label>
    <arm_group_label>amoxicillin clavulanate</arm_group_label>
    <other_name>500 milliliters of 0.9% Physiological Serum</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients over 18 years of age.

          -  Patients who require urgent surgical intervention and who come from the emergency
             service

          -  Patients affected by complicated intra-abdominal infection with peritonitis of more
             than one abdominal compartment or intra-abdominal abscess requiring open surgical
             intervention.

        Exclusion Criteria:

          -  Women patients with positive pregnancy test.

          -  Patients with primary peritonitis and liver cirrhosis.

          -  Patients who have received antibiotic treatment during the 72 hours prior to the
             surgical intervention (except that administered to UCIES as a treatment dose of the
             same process)

          -  Patients allergic to the antibiotic used in the study.

          -  Patients who have undergone a surgical procedure of recently opened abdomen (up to 30
             days before surgery), a prosthesis of synthetic material (mesh) or to which the
             surgical wound can not be closed according to the surgeon's criteria.

          -  Patients with an unfavorable life prognosis (ASA 5).
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Josep Maria Badia Perez, PH. D</last_name>
    <role>Study Director</role>
    <affiliation>Universitat Internacional de Catalunya</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Miquel Casal Rossell, MD</last_name>
    <phone>+376381420</phone>
    <email>miquelcasal@gmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Josep Maria Badia Perez, PH. D</last_name>
    <phone>+34 938 42 50 00</phone>
    <phone_ext>2575</phone_ext>
    <email>jmbadia@fhag.es</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Hospital General de Granollers</name>
      <address>
        <city>Granollers</city>
        <state>Barcelona</state>
        <zip>08402</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Miquel Casal</last_name>
      <phone>376381420</phone>
      <email>miquelcasal@gmail.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <reference>
    <citation>Rosen HR, Marczell AP, Czerwenka E, Stierer MO, Spoula H, Wasl H. Local gentamicin application for perineal wound healing following abdominoperineal rectum excision. Am J Surg. 1991 Nov;162(5):438-41.</citation>
    <PMID>1951905</PMID>
  </reference>
  <reference>
    <citation>Sociedad Española de Medicina Preventiva, Salud Pública e Higiene (SEMPSPH). (2015). Evolución EPINE 1990-2015 de la prevalencia de las infecciones nosocomiales en los hospitales españoles. EPINE. 1990-2015. Madrid.</citation>
  </reference>
  <reference>
    <citation>X.Guirao, J. A. (2006). Infecciones quirúrgicas (Guías clínicas de la asociación española de cirujanos).</citation>
  </reference>
  <results_reference>
    <citation>National Nosocomial Infections Surveillance (NNIS) report, data summary from October 1986-April 1996, issued May 1996. A report from the National Nosocomial Infections Surveillance (NNIS) System. Am J Infect Control. 1996 Oct;24(5):380-8.</citation>
    <PMID>8902113</PMID>
  </results_reference>
  <results_reference>
    <citation>Anderson DJ, Sexton DJ, Kanafani ZA, Auten G, Kaye KS. Severe surgical site infection in community hospitals: epidemiology, key procedures, and the changing prevalence of methicillin-resistant Staphylococcus aureus. Infect Control Hosp Epidemiol. 2007 Sep;28(9):1047-53. Epub 2007 Jul 12.</citation>
    <PMID>17932825</PMID>
  </results_reference>
  <results_reference>
    <citation>Simmons BP. Cdc guidelines on infection control. Infect Control. 1982 Mar-Apr;3(2 Suppl):187-96.</citation>
    <PMID>6918373</PMID>
  </results_reference>
  <results_reference>
    <citation>Charalambous CP, Tryfonidis M, Swindell R, Lipsett AP. When should old therapies be abandoned? A modern look at old studies on topical ampicillin. J Infect. 2003 Oct;47(3):203-9. Review. Erratum in: J Infect. 2008 Apr;56(4):297. Charalambous, Charalambos [corrected to Charalambous, Charalambos P].</citation>
    <PMID>12963381</PMID>
  </results_reference>
  <results_reference>
    <citation>Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40(5):373-83.</citation>
    <PMID>3558716</PMID>
  </results_reference>
  <results_reference>
    <citation>Chura JC, Boyd A, Argenta PA. Surgical site infections and supplemental perioperative oxygen in colorectal surgery patients: a systematic review. Surg Infect (Larchmt). 2007 Aug;8(4):455-61. Review.</citation>
    <PMID>17883362</PMID>
  </results_reference>
  <results_reference>
    <citation>Culver DH, Horan TC, Gaynes RP, Martone WJ, Jarvis WR, Emori TG, Banerjee SN, Edwards JR, Tolson JS, Henderson TS, et al. Surgical wound infection rates by wound class, operative procedure, and patient risk index. National Nosocomial Infections Surveillance System. Am J Med. 1991 Sep 16;91(3B):152S-157S.</citation>
    <PMID>1656747</PMID>
  </results_reference>
  <results_reference>
    <citation>Friberg O, Svedjeholm R, Söderquist B, Granfeldt H, Vikerfors T, Källman J. Local gentamicin reduces sternal wound infections after cardiac surgery: a randomized controlled trial. Ann Thorac Surg. 2005 Jan;79(1):153-61; discussion 161-2.</citation>
    <PMID>15620935</PMID>
  </results_reference>
  <results_reference>
    <citation>Lazar HL, Ketchedjian A, Haime M, Karlson K, Cabral H. Topical vancomycin in combination with perioperative antibiotics and tight glycemic control helps to eliminate sternal wound infections. J Thorac Cardiovasc Surg. 2014 Sep;148(3):1035-8; 1038-40. doi: 10.1016/j.jtcvs.2014.06.045. Epub 2014 Jul 2.</citation>
    <PMID>25129595</PMID>
  </results_reference>
  <results_reference>
    <citation>Garner JS. CDC guideline for prevention of surgical wound infections, 1985. Supersedes guideline for prevention of surgical wound infections published in 1982. (Originally published in November 1985). Revised. Infect Control. 1986 Mar;7(3):193-200.</citation>
    <PMID>3633903</PMID>
  </results_reference>
  <results_reference>
    <citation>Abdullah KG, Attiah MA, Olsen AS, Richardson A, Lucas TH. Reducing surgical site infections following craniotomy: examination of the use of topical vancomycin. J Neurosurg. 2015 Dec;123(6):1600-4. doi: 10.3171/2014.12.JNS142092. Epub 2015 Jun 19.</citation>
    <PMID>26090835</PMID>
  </results_reference>
  <results_reference>
    <citation>Kang DG, Holekamp TF, Wagner SC, Lehman RA Jr. Intrasite vancomycin powder for the prevention of surgical site infection in spine surgery: a systematic literature review. Spine J. 2015 Apr 1;15(4):762-70. doi: 10.1016/j.spinee.2015.01.030. Epub 2015 Jan 28. Review.</citation>
    <PMID>25637469</PMID>
  </results_reference>
  <results_reference>
    <citation>Kirby JP, Mazuski JE. Prevention of surgical site infection. Surg Clin North Am. 2009 Apr;89(2):365-89, viii. doi: 10.1016/j.suc.2009.01.001. Review.</citation>
    <PMID>19281889</PMID>
  </results_reference>
  <results_reference>
    <citation>Krukowski ZH, Irwin ST, Denholm S, Matheson NA. Preventing wound infection after appendicectomy: a review. Br J Surg. 1988 Oct;75(10):1023-33. Review.</citation>
    <PMID>3064867</PMID>
  </results_reference>
  <results_reference>
    <citation>Mangram AJ, Horan TC, Pearson ML, Silver LC, Jarvis WR. Guideline for prevention of surgical site infection, 1999. Hospital Infection Control Practices Advisory Committee. Infect Control Hosp Epidemiol. 1999 Apr;20(4):250-78; quiz 279-80.</citation>
    <PMID>10219875</PMID>
  </results_reference>
  <results_reference>
    <citation>Musters GD, Burger JW, Buskens CJ, Bemelman WA, Tanis PJ. Local Application of Gentamicin in the Prophylaxis of Perineal Wound Infection After Abdominoperineal Resection: A Systematic Review. World J Surg. 2015 Nov;39(11):2786-94. doi: 10.1007/s00268-015-3159-5. Review.</citation>
    <PMID>26170157</PMID>
  </results_reference>
  <results_reference>
    <citation>Leaper D, Burman-Roy S, Palanca A, Cullen K, Worster D, Gautam-Aitken E, Whittle M; Guideline Development Group. Prevention and treatment of surgical site infection: summary of NICE guidance. BMJ. 2008 Oct 28;337:a1924. doi: 10.1136/bmj.a1924.</citation>
    <PMID>18957455</PMID>
  </results_reference>
  <results_reference>
    <citation>Rutten HJ, Nijhuis PH. Prevention of wound infection in elective colorectal surgery by local application of a gentamicin-containing collagen sponge. Eur J Surg Suppl. 1997;(578):31-5.</citation>
    <PMID>9167147</PMID>
  </results_reference>
  <results_reference>
    <citation>Perencevich EN, Sands KE, Cosgrove SE, Guadagnoli E, Meara E, Platt R. Health and economic impact of surgical site infections diagnosed after hospital discharge. Emerg Infect Dis. 2003 Feb;9(2):196-203.</citation>
    <PMID>12603990</PMID>
  </results_reference>
  <results_reference>
    <citation>Nichols RL. Preventing surgical site infections: a surgeon's perspective. Emerg Infect Dis. 2001 Mar-Apr;7(2):220-4. Review.</citation>
    <PMID>11294711</PMID>
  </results_reference>
  <results_reference>
    <citation>Serrano-Heranz R. [Antimicrobial prophylaxis for surgery]. Rev Esp Quimioter. 2006 Dec;19(4):323-31. Review. Spanish.</citation>
    <PMID>17235400</PMID>
  </results_reference>
  <results_reference>
    <citation>Schultz A, Jørgensen PM, Jørgensen SP. Septic complications after appendicectomy for perforated appendicitis. A controlled clinical trial metronidazole and topical ampicillin. Acta Chir Scand. 1983;149(5):517-20.</citation>
    <PMID>6356732</PMID>
  </results_reference>
  <results_reference>
    <citation>Sessler DI, Akça O. Nonpharmacological prevention of surgical wound infections. Clin Infect Dis. 2002 Dec 1;35(11):1397-404. Epub 2002 Nov 13.</citation>
    <PMID>12439804</PMID>
  </results_reference>
  <results_reference>
    <citation>Tweed C. Prevention of surgical wound infection: prophylactic antibiotics in colorectal surgery. J Wound Care. 2005 May;14(5):202-5. Review.</citation>
    <PMID>15909433</PMID>
  </results_reference>
  <results_reference>
    <citation>Vasavada AR, Gajjar D, Raj SM, Vasavada V, Vasavada V. Comparison of 2 moxifloxacin regimens for preoperative prophylaxis: prospective randomized triple-masked trial. Part 1: aqueous concentration of moxifloxacin. J Cataract Refract Surg. 2008 Aug;34(8):1379-82. doi: 10.1016/j.jcrs.2008.04.027.</citation>
    <PMID>18655991</PMID>
  </results_reference>
  <results_reference>
    <citation>Wilson AP, Treasure T, Sturridge MF, Grüneberg RN. A scoring method (ASEPSIS) for postoperative wound infections for use in clinical trials of antibiotic prophylaxis. Lancet. 1986 Feb 8;1(8476):311-3.</citation>
    <PMID>2868173</PMID>
  </results_reference>
  <results_reference>
    <citation>Yan H, He J, Chen S, Yu S, Fan C. Intrawound application of vancomycin reduces wound infection after open release of post-traumatic stiff elbows: a retrospective comparative study. J Shoulder Elbow Surg. 2014 May;23(5):686-92. doi: 10.1016/j.jse.2014.01.049.</citation>
    <PMID>24745317</PMID>
  </results_reference>
  <results_reference>
    <citation>Badía JM, Martínez-Ródenas F, Oms LM, Valverde J, Franch G, Rosales A, Serrano R, Sitges-Serra A. [A randomized prospective study of antibiotic prophylaxis compared to lavage of the surgical wound in nonperforating appendicitis]. Med Clin (Barc). 1994 Jul 9;103(6):201-4. Spanish.</citation>
    <PMID>7967862</PMID>
  </results_reference>
  <results_reference>
    <citation>Badia JM, de la Torre R, Farré M, Gaya R, Martínez-Ródenas F, Sancho JJ, Sitges-Serra A. Inadequate levels of metronidazole in subcutaneous fat after standard prophylaxis. Br J Surg. 1995 Apr;82(4):479-82.</citation>
    <PMID>7613890</PMID>
  </results_reference>
  <results_reference>
    <citation>Badia JM, Torres JM, Tur C, Sitges-Serra A. Saline wound irrigation reduces the postoperative infection rate in guinea pigs. J Surg Res. 1996 Jul 1;63(2):457-9.</citation>
    <PMID>8661242</PMID>
  </results_reference>
  <results_reference>
    <citation>Clavien PA, Barkun J, de Oliveira ML, Vauthey JN, Dindo D, Schulick RD, de Santibañes E, Pekolj J, Slankamenac K, Bassi C, Graf R, Vonlanthen R, Padbury R, Cameron JL, Makuuchi M. The Clavien-Dindo classification of surgical complications: five-year experience. Ann Surg. 2009 Aug;250(2):187-96. doi: 10.1097/SLA.0b013e3181b13ca2.</citation>
    <PMID>19638912</PMID>
  </results_reference>
  <results_reference>
    <citation>Dindo D, Demartines N, Clavien PA. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg. 2004 Aug;240(2):205-13.</citation>
    <PMID>15273542</PMID>
  </results_reference>
  <verification_date>April 2019</verification_date>
  <study_first_submitted>May 30, 2018</study_first_submitted>
  <study_first_submitted_qc>June 27, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">June 29, 2018</study_first_posted>
  <last_update_submitted>April 14, 2019</last_update_submitted>
  <last_update_submitted_qc>April 14, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">April 16, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Universitat Internacional de Catalunya</investigator_affiliation>
    <investigator_full_name>Miquel Casal Rossell</investigator_full_name>
    <investigator_title>General Surgeon</investigator_title>
  </responsible_party>
  <keyword>topical antibiotic</keyword>
  <keyword>surgical wound infection</keyword>
  <keyword>prevention of surgical wound infection</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Infection</mesh_term>
    <mesh_term>Communicable Diseases</mesh_term>
    <mesh_term>Wound Infection</mesh_term>
    <mesh_term>Surgical Wound Infection</mesh_term>
    <mesh_term>Surgical Wound</mesh_term>
    <mesh_term>Wounds and Injuries</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Amoxicillin</mesh_term>
    <mesh_term>Clavulanic Acid</mesh_term>
    <mesh_term>Clavulanic Acids</mesh_term>
    <mesh_term>Amoxicillin-Potassium Clavulanate Combination</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

